about
Adenosine-mediated alteration of vascular reactivity and inflammation in a murine model of asthmaUtility of Dexrazoxane for the Attenuation of Epirubicin-Induced Genetic Alterations in Mouse Germ CellsProtective effects of phosphodiesterase 2 inhibitor on depression- and anxiety-like behaviors: involvement of antioxidant and anti-apoptotic mechanismsInvolvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma.Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice.A(1) adenosine receptor-mediated PKC and p42/p44 MAPK signaling in mouse coronary artery smooth muscle cells.Airway and systemic oxidant-antioxidant dysregulation in asthma: a possible scenario of oxidants spill over from lung into blood.Adenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T+ Itpr3tf/J mouse model of autism.Immune Alterations in CD8(+) T Cells Are Associated with Neuronal C-C and C-X-C Chemokine Receptor Regulation Through Adenosine A2A Receptor Signaling in a BTBR T(+) Itpr3(tf)/J Autistic Mouse Model.Resveratrol treatment attenuates chemokine receptor expression in the BTBR T+tf/J mouse model of autism.Psoriasis-like inflammation leads to renal dysfunction via upregulation of NADPH oxidases and inducible nitric oxide synthase.Toll-like receptor 4 signaling is associated with upregulated NADPH oxidase expression in peripheral T cells of children with autism.Psoriatic inflammation enhances allergic airway inflammation through IL-23/STAT3 signaling in a murine model.STA-21, a STAT-3 inhibitor, attenuates the development and progression of inflammation in collagen antibody-induced arthritis.β-1,3-Glucan reverses aflatoxin B1-mediated suppression of immune responses in mice.Design and Synthesis of N-Arylphthalimides as Inhibitors of Glucocorticoid-Induced TNF Receptor-Related Protein, Proinflammatory Mediators, and Cytokines in Carrageenan-Induced Lung Inflammation.Olmesartan attenuates tacrolimus-induced biochemical and ultrastructural changes in rat kidney tissue.TLR-7 agonist attenuates airway reactivity and inflammation through Nrf2-mediated antioxidant protection in a murine model of allergic asthma.Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.Functional inhibition of PAR2 alleviates allergen-induced airway hyperresponsiveness and inflammation.Upregulation of IL-9 and JAK-STAT signaling pathway in children with autism.Upregulation of peripheral CXC and CC chemokine receptor expression on CD4+ T cells is associated with immune dysregulation in children with autism.Dexrazoxane Averts Idarubicin-Evoked Genomic Damage by Regulating Gene Expression Profiling Associated With the DNA Damage-Signaling Pathway in BALB/c Mice.Acute lung injury leads to depression-like symptoms through upregulation of neutrophilic and neuronal NADPH oxidase signaling in a murine model.Increased oxidative stress in acute exacerbations of asthma.GPR43 activation enhances psoriasis-like inflammation through epidermal upregulation of IL-6 and dual oxidase 2 signaling in a murine model.Imbalance between the anti- and pro-inflammatory milieu in blood leukocytes of autistic children.Airway oxidative stress causes vascular and hepatic inflammation via upregulation of IL-17A in a murine model of allergic asthma.A novel A1 adenosine receptor antagonist, L-97-1 [3-[2-(4-aminophenyl)-ethyl]-8-benzyl-7-{2-ethyl-(2-hydroxy-ethyl)-amino]-ethyl}-1-propyl-3,7-dihydro-purine-2,6-dione], reduces allergic responses to house dust mite in an allergic rabbit model of asOxidative airway inflammation leads to systemic and vascular oxidative stress in a murine model of allergic asthma.Proteinase activated receptor-2-mediated dual oxidase-2 up-regulation is involved in enhanced airway reactivity and inflammation in a mouse model of allergic asthma.Acute glutathione depletion leads to enhancement of airway reactivity and inflammation via p38MAPK-iNOS pathway in allergic mice.Toll-like receptors, NF-κB, and IL-27 mediate adenosine A2A receptor signaling in BTBR T+ Itpr3tf/J mice.Glutathione modulation during sensitization as well as challenge phase regulates airway reactivity and inflammation in mouse model of allergic asthma.The tyrosine kinase inhibitor tyrphostin AG126 reduces activation of inflammatory cells and increases Foxp3+ regulatory T cells during pathogenesis of rheumatoid arthritis.Histamine 4 receptor promotes expression of costimulatory B7.1/B7.2 molecules, CD28 signaling and cytokine production in stress-induced immune responses.Systemic inflammation in asocial BTBR T+ tf/J mice predisposes them to increased psoriatic inflammation.Glucose-6-phosphate dehydrogenase inhibition attenuates acute lung injury through reduction in NADPH oxidase derived reactive oxygen species.Corrigendum to "Psoriatic inflammation causes hepatic inflammation with concomitant dysregulation in hepatic metabolism via IL-17A/IL-17 receptor signaling in a murine model" [Immunobiology 222 (2) (February 2017) 128-136].Adenosine A2A receptor signaling affects IL-21/IL-22 cytokines and GATA3/T-bet transcription factor expression in CD4+ T cells from a BTBR T+ Itpr3tf/J mouse model of autism.
P50
Q28397454-F9DDD854-95E7-4DF5-9E50-1E68AA876E94Q28554422-00F6B9B3-59E7-49A2-9429-7C56705A92D7Q33821243-FFAACE7E-C1F3-4ADE-8F41-A77EA77C1A96Q33994883-CC19C2C0-79F0-45F4-B139-212EEBC442D3Q34034484-51973219-6137-43BF-ACD4-7F22B0F07FFBQ37372351-8E3C03B2-0988-42F3-87DD-A341E6F37FBAQ38220198-3A664AE0-8DFE-4CC4-BFF5-F05BBF1C73B6Q38691389-9336DB17-7C70-4592-B96A-33349FD916EAQ38728524-6FAE2AA5-8F6E-4AE3-8F12-D5BD39B9B713Q38799281-9A4CFE55-2C52-409F-92AF-99BDBD1CF6C9Q38935460-9FFEBBA8-AFFD-4C00-B64C-FC087AAE78D7Q39052127-FD5C84BD-B7A8-4AB3-868A-9CCD60028CBCQ39094732-F32C9289-5640-42C1-95C8-3EED6A1DBAFFQ39311176-235541F9-E0C9-4FE6-8C5E-DA3FD5E04E38Q39903184-140DD7AB-0B70-40F0-A08A-50AF7539CA42Q40321251-93D5282F-59BA-4D41-9208-2D23C9D6029AQ40736861-786E4D8B-E317-4125-8BA7-02E3D886579CQ40925729-D6FA8A58-37AF-4448-BE3D-45AFB7548E5AQ42701254-E18073F6-3376-49C3-85F4-DEEDDF034C4AQ45980761-24683379-A986-4588-AF4E-0AA54B311DB7Q46171565-C7B37D6A-3655-4645-BECA-9475F8547B6CQ46231753-75D1E3B7-7750-4BB7-B472-9FABE910778CQ46296013-C0A85527-35CF-42EF-8DFA-4B2BE3116160Q46378443-AD41A9CE-8685-4530-883A-ABAC9C751623Q46413557-206E1119-5C09-46E0-8C11-55911D3B3F49Q46416159-6E2A12E9-24F3-4D64-8A5F-06AC7B606704Q46500470-FCCAE629-EE84-4D91-9E81-26D8B6744CA3Q46583416-E499A9F9-1058-452C-89C0-24BE3BCC9AD4Q46601617-F8640A5C-CB7D-4756-884E-A5580FB66D6FQ46748524-B306AC6F-CD80-4576-BBC3-B527CBA5A082Q46772277-31149998-AD1E-4999-89EB-768B28A75797Q46872681-C4944AFA-79A8-4DCA-90AE-FB64C1C411D2Q46886210-AA908ECE-2F9B-4F8A-89CB-B348C0FDADC7Q46904438-A5C36C90-9038-489F-A856-1855FEF06DB3Q46981173-5EC62DD8-6A9B-43EC-96F2-EA6B8C37A8A2Q46983009-60549002-CA3C-4581-AD2A-4A5538EF8694Q47210953-9EFA528C-9AF7-47F3-864A-AF1EB3C3C81AQ47249156-0610520B-412B-4629-8C98-004850CE51D3Q47650200-6C6C223F-C94C-4F87-B157-5CC01B7D04FAQ47741689-FCCF5B40-5F6C-49AE-AC6E-DF1BB404DDFD
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
A Nadeem
@en
A Nadeem
@nl
type
label
A Nadeem
@en
A Nadeem
@nl
prefLabel
A Nadeem
@en
A Nadeem
@nl
P31
P496
0000-0003-2038-8367